Guggenheim Capital LLC Guardant Health, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 125,680 shares of GH stock, worth $3.97 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

125,680

Previous 137,811 8.8%

Holding current value

$3.97 Million

Previous $3.98 Million 27.59%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$22.3 - $36.29 $270,521 - $440,233	-12,131 Reduced 8.8%	125,680 $2.88 Million
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $279,168 - $553,124	-17,372 Reduced 11.19%	137,811 $3.98 Million
Q1 2024 May 14, 2024	SELL	$17.13 - $26.91 $113,503 - $178,305	-6,626 Reduced 4.09%	155,183 $3.2 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $247,738 - $338,660	11,480 Added 7.64%	161,809 $4.38 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $446,881 - $692,320	17,321 Added 13.02%	150,329 $4.46 Million
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $187,329 - $340,037	8,946 Added 7.21%	133,008 $4.76 Million
Q1 2023 May 10, 2023	BUY	$22.92 - $33.76 $166,949 - $245,907	7,284 Added 6.24%	124,062 $2.91 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $16,383 - $38,498	644 Added 0.55%	116,778 $3.18 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $309,549 - $432,490	7,090 Added 6.5%	116,134 $6.25 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $231,511 - $621,352	8,033 Added 7.95%	109,044 $4.4 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $1.41 Million - $2.94 Million	29,270 Added 40.8%	101,011 $6.69 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.79 Million - $2.43 Million	20,194 Added 39.18%	71,741 $7.18 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $642,400 - $859,633	6,504 Added 14.44%	51,547 $6.44 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $455,216 - $687,074	4,147 Added 10.14%	45,043 $5.59 Million
Q1 2021 May 13, 2021	BUY	$127.04 - $179.1 $632,405 - $891,559	4,978 Added 13.86%	40,896 $6.24 Million
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $466,013 - $633,705	-4,662 Reduced 11.49%	35,918 $4.63 Million
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $1.29 Million - $1.79 Million	-16,026 Reduced 28.31%	40,580 $4.54 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $628,914 - $1.01 Million	10,397 Added 22.5%	56,606 $4.59 Million
Q1 2020 Jun 02, 2020	SELL	$59.04 - $88.81 $599,433 - $901,687	-10,153 Reduced 18.01%	46,209 $3.22 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $3.35 Million - $4.67 Million	56,362 New	56,362 $4.4 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Guardant Health, Inc. Transaction History